Of the 23/60 patients in CR/CRi (12/23 with treatment-naïve AML and 11/37 R/R AML), 3 had a NPM1-mutated AML (1 treatment-naïve and 2 R/R). This evidence concerns the gene NPM1 and acute myeloid leukemia.